News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ARYx Therapeutics, Inc. Reports Second Quarter 2009 Results
August 13, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FREMONT, Calif.--(BUSINESS WIRE)--ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of operations and provided a general business update for the second quarter ended June 30, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Licensing
AbbVie grooves with DISCO’s solid tumor tech in up to $2.5B licensing deal
November 19, 2026
·
1 min read
·
Annalee Armstrong
Layoffs
9 biotechs will cut at least half their California workforces
November 19, 2026
·
6 min read
·
Angela Gabriel
Drug Development
Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns
November 18, 2026
·
2 min read
·
Gabrielle Masson
Government
Government actions are hitting smaller biotechs the hardest: Report
November 18, 2026
·
2 min read
·
Nick Paul Taylor